Narrow search
Showing 1 - 10 of 1,678
Cover Image
Substitutability between drugs, innovation, and fiscal policy in the pharmaceutical industry
Mello-Sampayo, Felipa de; Sousa-Vale, Sofia de; Camoes, … - In: Annals of economics and finance 16 (2015) 2, pp. 273-289
Persistent link: https://www.econbiz.de/10011427811
Cover Image
The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry
Banerjee, Tannista; Siebert, Ralph - 2014
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10010229875
Cover Image
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017
Persistent link: https://www.econbiz.de/10011708133
Cover Image
Evaluating the US pharmaceutical patent policy
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Cover Image
Optimal patent policy for pharmaceutical industry
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2020
Persistent link: https://www.econbiz.de/10012439514
Cover Image
Impact of product patents on pharmaceutical market structure and prices in India
Chaudhuri, Sudip - 2018
Persistent link: https://www.econbiz.de/10011963838
Cover Image
Product patents and access to innovative medicines in a post-trips-era
Watal, Jayashree; Dai, Rong - 2019 - Manuscript date: 28 March 2019
This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era … the introduction of product patents in pharmaceuticals affect the likelihood of pharmaceutical firms to launch new and … finds that introduction of product patent for pharmaceuticals in the patent law has a positive effect on launch likelihood …
Persistent link: https://www.econbiz.de/10011992779
Cover Image
Chapter 12. Pharmaceutical Innovation
Scherer, F.M. - 2010
pharmaceuticals. The changing methods by which drugs are discovered, the links between companies and academic science, the changing …
Persistent link: https://www.econbiz.de/10014025164
Cover Image
Chapter Twelve. Markets for Pharmaceutical Products
Scott Morton, Fiona; Kyle, Margaret - In: Handbook of health economics : volume 2, (pp. 763-823). 2011
This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is …
Persistent link: https://www.econbiz.de/10014025576
Cover Image
Generics and new goods in pharmaceutical price indexes
Griliches, Zvi; Cockburn, Iain - 1993
Persistent link: https://www.econbiz.de/10000884439